01 aprile 2021 07:07
Fonte: Adnkronos
#salute-e-benessere
ZURICH and MOSCOW, April 1, 2021 /PRNewswire/ Acino announced today the completion of the acquisition of select portfolio of brands from the IlmixGroup group of companies in Russia. The transaction includes eight prescription pharmaceutical assets and food supplements in the areas of gynaecology, gynaecologic oncology, urology and dermatology. The parties also entered into manufacturing and supply agreements under which MiraxBioPharma, an IlmixGroup company, will continue to manufacture the products in Russia on behalf of Acino, providing uninterrupted access to patients. This acquisition further increases Acino s market share in Russia, reaching over 10% in its addressable market segments, and making the Top-65 list of pharmaceutical companies.